patent expiration

Annual Drug Patent Expirations for BYLVAY Bylvay is a drug marketed by Albireo and is included in one NDA. There are eight patents protecting this drug. This drug has one…
The post New patent expiration for Albireo drug BYLVAY appeared first on DrugPat…

LONHALA MAGNAIR KIT (glycopyrrolate) Sunovion resp Patent: 7,316,067 Expiration: Sep 6, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expirations…

Annual Drug Patent Expirations for AMITIZA Amitiza is a drug marketed by Sucampo Pharma Llc and is included in one NDA. It is available from three suppliers. There are nine…
The post New patent expiration for Sucampo Pharma drug AMITIZA appeared first …

Annual Drug Patent Expirations for LEVAQUIN Levaquin is a drug marketed by Janssen Pharms and is included in three NDAs. There is one patent protecting this drug and one Paragraph…
The post New patent expiration for Janssen Pharms drug LEVAQUIN appeare…

LEVAQUIN (levofloxacin) Janssen pharms Patent: 6,806,256 Expiration: Aug 26, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug …

Annual Drug Patent Expirations for VIBATIV Vibativ is a drug marketed by Cumberland Pharms and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent expiration for Cumberland Pharms drug VIBATIV appeare…

Annual Drug Patent Expirations for AFINITOR Afinitor is a drug marketed by Novartis and Novartis Pharm and is included in two NDAs. It is available from one supplier. There are…
The post New patent expiration for Novartis drug AFINITOR appeared first o…

Annual Drug Patent Expirations for AFINITOR+DISPERZ Afinitor Disperz is a drug marketed by Novartis Pharm and is included in one NDA. It is available from one supplier. There are two…
The post New patent expiration for Novartis Pharm drug AFINITOR DISP…

Annual Drug Patent Expirations for AFINITOR Afinitor is a drug marketed by Novartis and Novartis Pharm and is included in two NDAs. It is available from one supplier. There are…
The post New patent expiration for Novartis drug AFINITOR appeared first o…

AFINITOR (everolimus) Novartis Patent: 8,778,962 Expiration: Aug 18, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Pa…